We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+14.71%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$816B
AUM Growth
+$71.6B
Cap. Flow
-$12.2B
Cap. Flow %
-1.5%
Top 10 Hldgs %
32.14%
Holding
3,021
New
108
Increased
1,941
Reduced
738
Closed
64

Top Buys

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$2.03B
2
ROK icon
Rockwell Automation
ROK
+$1.44B
3
ADSK icon
Autodesk
ADSK
+$1.15B
4
C icon
Citigroup
C
+$975M
5
COP icon
ConocoPhillips
COP
+$967M

Sector Composition

Rank Sector Weight
1 Technology 32.21%
2 Healthcare 15.42%
3 Financials 10.99%
4 Consumer Discretionary 10.39%
5 Communication Services 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMA
2951
PUT
DELISTED
Comerica
CMA
-3,592,400
Closed -$200M
CRH icon
2952
CRH
CRH
$65.3B
-3,458
Closed -$240K
CUE icon
2953
Cue Biopharma
CUE
$124M
-608
Closed -$49K
CVAC
2954
DELISTED
CureVac
CVAC
-2,324,274
Closed -$9.79M
GMAB icon
2955
Genmab
GMAB
$19.2B
-189,491
Closed -$6.03M
HSAI
2956
Hesai Group
HSAI
$3.02B
-917,240
Closed -$8.17M
HURC icon
2957
Hurco Companies Inc
HURC
$144M
-12,500
Closed -$270K
HWBK icon
2958
Hawthorn Bancshares
HWBK
$276M
-8,222
Closed -$209K
CYPH
2959
Cypherpunk Technologies Inc
CYPH
$70.5M
-119,200
Closed -$495K
LYG icon
2960
Lloyds Banking Group
LYG
$90.1B
-1,480,127
Closed -$3.54M
OTLK icon
2961
Outlook Therapeutics
OTLK
$156M
-1,668
Closed -$14K
PHUN icon
2962
Phunware
PHUN
$43M
-3,094
Closed -$13K
RNAC icon
2963
Cartesian Therapeutics
RNAC
$266M
-901
Closed -$19K
SERA icon
2964
Sera Prognostics
SERA
$76M
-151,933
Closed -$909K
SQM icon
2965
Sociedad Química y Minera de Chile
SQM
$21B
-917,477
Closed -$55.3M
UHAL icon
2966
U-Haul Holding Co
UHAL
$14.5B
-3,143
Closed -$226K
VOD icon
2967
Vodafone
VOD
$37.3B
-18,263,998
Closed -$159M
VOX icon
2968
Vanguard Communication Services ETF
VOX
$5.84B
-1,752
Closed -$207K
VRM icon
2969
Vroom Inc
VRM
$52.3M
-1,073
Closed -$52K
XLB icon
2970
State Street Materials Select Sector SPDR ETF
XLB
$8.6B
-4,742
Closed -$203K
XME icon
2971
State Street SPDR S&P Metals & Mining ETF
XME
$4.5B
-3,552
Closed -$213K
XRT icon
2972
State Street SPDR S&P Retail ETF
XRT
$642M
-2,896
Closed -$210K
XXII
2973
22nd Century Group
XXII
$1.36M
0
-$5K
ZION icon
2974
PUT
Zions Bancorporation
ZION
$10.5B
-5,072,600
Closed -$223M
MMAT
2975
DELISTED
Meta Materials Inc. Common Stock
MMAT
-7,186
Closed -$48K

Similar funds

T. Rowe Price Associates's Q1 2024 Portfolio in Review

As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
  • T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
  • T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
  • T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
  • T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.